Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies SAN FRANCISCO and SUZHOU, China, April 30, 2025 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireApril 30, 2025
Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong SHANGHAI, April 30, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or… CISION PRNewswireApril 30, 2025
KT Corp. Files 2024 Annual Report on Form 20-F SEOUL, South Korea, April 30, 2025 /PRNewswire/ — KT Corporation (NYSE: KT), South Korea’s leading… CISION PRNewswireApril 30, 2025
Press Release【C.S Group】: Launches Antcin A-Based Veterinary Drug Initiative Across Taiwan and China TAIPEI, April 30, 2025 /PRNewswire/ — Cordyceps Sunshine Biotech Holdings Co., Ltd.【C.S… CISION PRNewswireApril 30, 2025
Nisun International Enterprise Development Group Co., Ltd Reports Full Year 2024 Financial Results Highlights Positive Earnings Per Share and Substantial Cash Position of $11.11/share Amidst… CISION PRNewswireApril 30, 2025
Press Releasee& achieves AED 16.9 billion consolidated revenue growing 18.7% YoY in Q1 2025 Consolidated net profit increased to AED 5.4 billion, reflecting a 129.9 per… CISION PRNewswireApril 30, 2025
Press ReleaseVOC.AI Secures 15 Million Dollars Funding to Fuel Global Growth and Transform AI-Driven Customer Service Solutions SILICON VALLEY, Calif., April 30, 2025 /PRNewswire/ — VOC.AI, a North America leader in… CISION PRNewswireApril 30, 2025
Henley & Partners Responds to European Court of Justice Ruling on Malta's Citizenship Program LONDON, April 30, 2025 /PRNewswire/ — Henley & Partners is disappointed by the… CISION PRNewswireApril 29, 2025
